Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet TELMISARTAN/HIDROCLOROTIAZIDA TERAPIA 80mg / 25mg tablets
- Product code:
- W60430005
- Quantity:
- 28
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- telmisartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)
- ATC
- C09DA07 — Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
This combination of telmisartan and hydrochlorothiazide is used for the treatment of hypertension in patients not adequately controlled with a single medication. Telmisartan blocks angiotensin II receptors, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, electrolyte imbalances, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, electrolyte imbalances, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about TELMISARTAN/HIDROCLOROTIAZIDA TERAPIA 80mg / 25mg
- Substance:
- telmisartan + hydrochlorothiazide
- Date of latest medicines list:
- 01-01-2019
- Product code:
- W60430005
- Concentration:
- 80mg / 25mg
- Pharmaceutical form:
- tablets
- Quantity:
- 28
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for telmisartan + hydrochlorothiazide
Concentrations available for telmisartan + hydrochlorothiazide
- 40/12.5mg
- 40mg/12.5mg
- 80/25mg
- 80mg/12.5mg
- 80mg/25mg